Systemic lupus erythematosus epidemiology and demographics

Revision as of 17:28, 3 July 2017 by Skazmi (talk | contribs)
Jump to navigation Jump to search

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus epidemiology and demographics

on Systemic lupus erythematosus epidemiology and demographics

Systemic lupus erythematosus epidemiology and demographics in the news

Blogs onSystemic lupus erythematosus epidemiology and demographics

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

Worldwide, the prevalence of systemic lupus erythematosus is 60 per 100,000 persons. In North America, South America, Europe, and Asia, the incidence of systemic lupus erythematosus ranges from a low of 1 per 100,000 persons to a high of 20 per 100,000 persons with an average prevalence of 12 per 100,000 persons. The overall mortality rate of lupus is very high, estimated to have approximately 50,000 death of 100,000. Women are more commonly affected with systemic lupus erythematosus than men. Systemic lupus erythematosus flare ups are more prevalent in women. Systemic lupus erythematosus is more prevalent in the African race and Asian races.

Epidemiology and Demographics

Prevalence

  • Worldwide, the prevalence of systemic lupus erythematosus is 60 per 100,000 persons.[1]
  • Worldwide, a conservative estimate states that over 5 million people have lupus.
  • In United States, the prevalence of systemic lupus erythematosus ranges from a low of 20  per 100,000 persons to a high of 150 per 100,000 persons with an average prevalence of 25 per 100,000 persons.[1]

Incidence

  • In North America, South America, Europe, and Asia, the incidence of systemic lupus erythematosus ranges from a low of 1 per 100,000 persons to a high of 20 per 100,000 persons with an average prevalence of 12 per 100,000 persons.[1]
  • Systemic lupus erythematosus incidence has approximately tripled during the past 3-4 decades. The increase in incidence is mainly attributed to improvement in diagnostic tests, that has led to SLE diagnosis in earlier stages of the disease.

Case Fatality Rate

  • The overall mortality rate of lupus is very high, estimated to have approximately 50,000 death of 100,000.[1]
  • Approximately one third of deaths from SLE occur among persons aged <45 years.
  • Non-Causcasian race is a risk factor for death from SLE.
  • SLE mortality is most frequently caused by active SLE or by associated organ failure, infection, or cardiovascular disease from accelerated atherosclerosis.

Age

  • The disease is more common in the young patient population even though it can occur at any age.
  • Sixty-five percent of patients with SLE have disease onset between the ages of 16 and 55.

Gender

  • Women are more commonly affected with systemic lupus erythematosus than men. Systemic lupus erythematosus flare ups are more prevalent in women.
  • The female to male ratio is approximately 5 to 1.
  • Men with lupus tend to have higher frequencies of renal disease, skin manifestations, cytopenias, serositis, neurologic involvement, thrombosis, cardiovascular disease, hypertension, and vasculitis than women.

Race

  • Systemic lupus erythematosus is more prevalent in the African race and Asian races.
  • The disease appears to be more common in urban than rural areas.
  • Non-Causcasian race is a risk factor for death from SLE.
  • SLE occurs with much greater severity among African-American women, who suffer more severe symptoms as well as a higher case fatality rate. [1][2]

References

  1. 1.0 1.1 1.2 1.3 1.4 Lupus and African-American women
  2. "Trends in Deaths from Systemic Lupus Erythematosus --- United States, 1979--1998".

Template:WH Template:WS